Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-07 Purchase | 2024-01-30 4:39 pm | Wave Life Sciences Ltd. | WVE | GSK plc 10% Owner | 3,300,000 | $5 | $16,500,000 | 13,983,761 (Indirect) | View |
| 2021-07-02 Purchase | 2021-07-06 4:38 pm | CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner | 275,000 | $18 | $4,950,000 | 1,007,583 (Indirect) | View |
| 2021-05-20 Sale | 2021-05-24 5:04 pm | Innoviva Inc. | INVA | GLAXOSMITHKLINE PLC 10% Owner | 32,005,260 | $12.25 | $392,064,435 | 0 (Indirect) | View |
| 2021-02-17 Purchase | 2021-02-19 4:50 pm | Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director | 150,000 | $18 | $2,700,000 | 1,183,663 (Indirect) | View |
| 2020-07-14 Sale | 2020-09-18 12:04 pm | BICYCLE THERAPEUTICS plc | BCYC | GLAXOSMITHKLINE PLC 10% Owner | 4,744 | $19.36 | $91,826 | 1,910,531 (Indirect) | View |
| 2020-07-24 Purchase | 2020-07-30 8:56 pm | GENOCEA BIOSCIENCES INC. | GNCA | GLAXOSMITHKLINE PLC 10% Owner | 1,260,504 | $2.25 | $2,836,134 | 5,886,893 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-22 4:18 pm | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 361,111 | $18 | $6,499,998 | 2,262,301 (Indirect) | View |
| 2020-07-14 Purchase | 2020-07-16 8:13 pm | Nkarta Inc. | NKTX | GLAXOSMITHKLINE PLC Director 10% Owner | 833,333 | $18 | $14,999,994 | 3,161,432 (Indirect) | View |
| 2020-05-21 Purchase | 2020-05-26 4:17 pm | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director | 83,333 | $60 | $4,999,980 | 2,253,660 (Indirect) | View |
| 2020-05-20 Sale | 2020-05-21 5:21 pm | Progyny Inc. | PGNY | GLAXOSMITHKLINE PLC 10% Owner | 4,000,000 | $25.75 | $103,000,000 | 6,238,244 (Indirect) | View |
| 2019-10-18 Purchase | 2019-10-22 5:36 pm | Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC Former 10% Owner | 357,142 | $28 | $9,999,976 | 2,982,855 (Indirect) | View |
| 2019-09-10 Purchase | 2019-09-12 4:18 pm | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director | 177,777 | $45 | $7,999,965 | 2,170,327 (Indirect) | View |
| 2019-07-01 Purchase | 2019-07-02 4:13 pm | Morphic Holding Inc. | MORF | GLAXOSMITHKLINE PLC Director | 333,333 | $15 | $4,999,995 | 2,633,772 (Indirect) | View |
| 2019-06-24 Purchase | 2019-06-26 10:46 am | GENOCEA BIOSCIENCES INC. | GNCA | GLAXOSMITHKLINE PLC 10% Owner | 1,857,142 | $3.5 | $6,499,997 | 3,365,884 (Indirect) | View |
| 2019-05-28 Purchase | 2019-05-30 5:47 pm | BICYCLE THERAPEUTICS plc | BCYC | GLAXOSMITHKLINE PLC Director 10% Owner | 385,714 | $14 | $5,399,996 | 1,915,275 (Indirect) | View |
| 2019-04-22 Purchase | 2019-04-24 7:28 pm | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director 10% Owner | 325,000 | $18 | $5,850,000 | 2,007,550 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-01-30 4:34 pm | N/A N/A | Wave Life Sciences Ltd. | WVE | GSK PLC 10% Owner | 0 | $0 | 10,683,761 (Indirect) | View |
Ownership | 2022-11-14 5:05 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | GSK PLC 10% Owner | 0 | $0 | 9,190,606 (Indirect) | View |
Ownership | 2022-11-04 4:11 pm | N/A N/A | 23andMe Holding Co. | ME | GSK PLC 10% Owner | 0 | $0 | 39,660,487 (Indirect) | View |
| 2022-09-16 Other | 2022-09-20 4:16 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner | 269,061,000 | $0 | 9,644,807 (Indirect) | View |
| 2022-09-16 Other | 2022-09-20 4:16 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner | 9,644,807 | $9.75 | 9,644,807 (Indirect) | View |
| 2021-07-02 Conversion | 2021-07-06 4:38 pm | N/A N/A | CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner | 13,331,791 | $0 | 1,007,583 (Indirect) | View |
Ownership | 2021-07-06 4:22 pm | N/A N/A | CVRx Inc. | CVRX | GLAXOSMITHKLINE PLC 10% Owner | 0 | $0 | 700,772 (Indirect) | View |
| 2021-06-21 Conversion | 2021-06-23 6:14 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner | 30,253,189 | $0 | 30,253,189 (Indirect) | View |
Ownership | 2021-06-17 5:56 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner | 0 | $0 | 30,253,189 (Indirect) | View |
| 2021-02-17 Conversion | 2021-02-19 4:50 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director | 13,016,132 | $0 | 1,183,663 (Indirect) | View |
Ownership | 2021-02-11 9:04 pm | N/A N/A | Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 1,033,663 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-22 4:18 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 13,997 | $0 | 2,262,301 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-22 4:18 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 11,510,727 | $0 | 2,262,301 (Indirect) | View |
Ownership | 2020-07-16 9:52 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 1,887,193 (Indirect) | View |
| 2020-07-14 Option Award | 2020-07-16 8:13 pm | N/A 2030-07-08 | Nkarta Inc. | NKTX | GLAXOSMITHKLINE PLC Director 10% Owner | 10,700 | $0 | 3,161,432 (Indirect) | View |
| 2020-07-14 Conversion | 2020-07-16 8:13 pm | N/A N/A | Nkarta Inc. | NKTX | GLAXOSMITHKLINE PLC Director 10% Owner | 10,941,813 | $0 | 3,161,432 (Indirect) | View |
Ownership(A) | 2020-07-14 4:48 pm | N/A N/A | Nkarta Inc. | NKTX | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 79,090 (Indirect) | View |
Ownership | 2020-07-09 8:58 pm | N/A N/A | Nkarta Inc. | NKTX | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 2,238,309 (Indirect) | View |
Ownership | 2020-01-02 4:06 pm | N/A N/A | Orchard Therapeutics plc | ORTX | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 12,455,252 (Indirect) | View |
| 2019-10-29 Conversion | 2019-10-31 6:27 pm | N/A N/A | Progyny Inc. | PGNY | GLAXOSMITHKLINE PLC 10% Owner | 9,821,190 | $0 | 10,238,244 (Indirect) | View |
Ownership | 2019-10-24 8:36 pm | N/A N/A | Progyny Inc. | PGNY | GLAXOSMITHKLINE PLC 10% Owner | 0 | $0 | 10,526,957 (Indirect) | View |
| 2019-07-22 Conversion | 2019-07-24 4:01 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | GLAXOSMITHKLINE PLC 10% Owner | 14,285,714 | $0 | 1,785,714 (Indirect) | View |
Ownership | 2019-07-17 7:37 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | GLAXOSMITHKLINE PLC 10% Owner | 0 | $0 | 1,785,714 (Indirect) | View |
| 2019-07-01 Conversion | 2019-07-02 4:13 pm | N/A N/A | Morphic Holding Inc. | MORF | GLAXOSMITHKLINE PLC Director | 2,300,439 | $0 | 2,633,772 (Indirect) | View |
Ownership | 2019-06-26 6:39 pm | N/A N/A | Morphic Holding Inc. | MORF | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 2,300,439 (Indirect) | View |
| 2019-06-11 Option Award | 2019-06-17 2:57 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | GLAXOSMITHKLINE PLC 10% Owner | 10,240 | $0 | 10,240 (Indirect) | View |
| 2019-05-28 Conversion | 2019-05-30 5:47 pm | N/A N/A | BICYCLE THERAPEUTICS plc | BCYC | GLAXOSMITHKLINE PLC Director 10% Owner | 2,599,933 | $0 | 1,915,275 (Indirect) | View |
Ownership | 2019-05-23 10:53 am | N/A N/A | BICYCLE THERAPEUTICS Ltd | BCYC | GLAXOSMITHKLINE PLC Director 10% Owner | 0 | $0 | 1,529,561 (Indirect) | View |
| 2019-04-22 Option Award | 2019-04-24 7:28 pm | N/A 2029-04-22 | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director 10% Owner | 15,000 | $0 | 2,007,550 (Indirect) | View |
| 2019-04-22 Conversion | 2019-04-24 7:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | GLAXOSMITHKLINE PLC Director 10% Owner | 8,087,618 | $0 | 2,007,550 (Indirect) | View |